ArticleWorld journal of surgical oncology2026
Oral paraneoplastic manifestations and findings associated with extra-oral surgically treated malignancies: a prospective cross-sectional study of 300 cases.
Article in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundTo assess the prevalence of oral paraneoplastic manifestations in patients with biopsy-confirmed extra-oral malignancies and to identify oral findings with potential paraneoplastic significance that could serve as new targets for dental screening.
methodsA single-center prospective cross-sectional study was performed. A total of 300 consecutive surgical oncology patients (April 2024–September 2025) underwent standardized oral examinations one day prior to planned oncologic surgery. Extraoral and intraoral findings—including mucosal changes, perfusion abnormalities, tongue morphology, and candidal colonization—were evaluated by oral medicine specialists. Only primary extra-oral malignancies were included and categorized into upper gastrointestinal, colorectal, hepatopancreatic, lung, and breast cancer. Mycological cultures were obtained in all patients. Statistical assessment used Chi-square test, multivariate stepwise selection logistic regression models and univariate models of selected confounders (SAS software).
resultsClassical paraneoplastic oral syndromes (e.g., paraneoplastic pemphigus, acanthosis nigricans) were not detected. Oral candidiasis was uncommon and appeared mainly in patients with advanced disease, suggesting limited usefulness as an early indicator. In contrast, labial and lingual hypoperfusion occurred significantly more often in gastrointestinal cancers (p ≤ 0.0001, labial hypoperfusion was differentiated in 25.5% (24/94) of gastrointestinal malignancies). Patients with breast cancer showed a markedly higher prevalence of tongue enlargement and dental impressions (both p < 0.0001, with tongue enlargement detected in 51,3% (80/159) of cases), as well as lateral deviation during protrusion (p = 0.0152).
conclusionTraditional oral paraneoplastic manifestations were virtually absent in this cohort. However, simple clinical findings—particularly perfusion changes and tongue morphology—showed frequent tumor-specific associations and may merit further investigation for the verification as potential early paraneoplastic indicators. As a pilot study, the results should be interpreted as hypothesis-generating. Following validation in large multicenter studies, these findings may bring a promising opportunity to strengthen the role of dentists in multidisciplinary prevention programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.